773136-66-6

Usage

Uses

Used in Pharmaceutical Synthesis:
Ethyl-2-fluoro-5-iodobenzoate is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs with specific therapeutic properties. Its unique fluoro-iodo structure allows for the creation of molecules with tailored pharmacological actions.
Used in Agrochemical Production:
In the agrochemical industry, Ethyl-2-fluoro-5-iodobenzoate serves as an intermediate in the synthesis of various agrochemicals, including pesticides and herbicides. Its incorporation into these products can enhance their effectiveness in controlling pests and weeds, thereby improving crop yields and quality.
Used in Organic Synthesis Research:
Ethyl-2-fluoro-5-iodobenzoate is utilized as a building block in organic synthesis research, where its unique reactivity and structural properties are leveraged to explore new chemical reactions and develop novel compounds with potential applications in various fields.
Safety Precautions:
It is important to handle Ethyl-2-fluoro-5-iodobenzoate with proper safety measures, as it may cause irritation to the skin, eyes, and respiratory system if not handled carefully. Appropriate personal protective equipment and handling procedures should be followed to minimize risks associated with this chemical compound.

InChI:InChI=1/C9H8FIO2/c1-2-13-9(12)7-5-6(11)3-4-8(7)10/h3-5H,2H2,1H3

Upstream product

• 64-17-5 ethanol 
• 124700-41-0 2-fluoro-5-iodobenzoic acid 

Downstream Products

• 1552285-72-9 C₁₃H₁₅FO₃ 

Relevant academic research and scientific papers

PET probe targeting tropomyosin receptor kinase TRK fusion protein, as well as synthesis and application thereof

The invention relates to a PET probe targeting tropomyosin receptor kinase TRK fusion protein, as well as synthesis and application thereof. The PET probe has a molecular structure as shown in the specification. Compared with the prior art, the novel TRK

4-METHYL-2,3,5,9,9B-PENTAAZA-CYCLOPENTA[A]NAPHTHALENES

The invention relates to 4-methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalene derivatives of general formula (I) which are inhibitors of phosphodiesterase 2 and/or 10, useful in treating central nervous system diseases and other diseases. In addition, the invention relates to processes for preparing pharmaceutical compositions as well as processes for manufacture the compounds according to the invention.

4-Methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes

The invention relates to 4-methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalene derivatives of general formula (I) which are inhibitors of phosphodiesterase 2 and/or 10, useful in treating central nervous system diseases and other diseases. In addition, the invention relates to processes for preparing pharmaceutical compositions as well as processes for manufacture the compounds according to the invention.

SUBSTITUTED SULFONAMIDES USEFUL AS ANTIAPOPTOTIC BCL INHIBITORS

Disclosed are compounds of Formula (I), or a pharmaceutically acceptable salt thereof, wherein: W and Q and G are defined herein. Also disclosed are methods of using such compounds as inhibitors of Bcl-2 family antiapoptotic proteins for the treatment of cancer; and pharmaceutical compositions comprising such compounds.